Product Description
Incrementally Modified Drugs of fenofibric acid (Sourced from: https://www.clinicaltrials.gov/ct2/show/NCT01501435)
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: HK inno.N
Company Location: Asia Pacific
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 1: Healthy Volunteers
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT01501435 |
CJ_FEN_101 | P1 |
Completed |
Healthy Volunteers |
2012-04-01 |
2020-07-16 |
Primary Endpoints|Treatments |
Recent News Events
Date |
Type |
Title |
|---|